ITCI Annual Working Capital
$544.25 M
-$110.47 M-16.87%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual working capital is $544.25 million, with the most recent change of -$110.47 million (-16.87%) on December 31, 2023. During the last 3 years, it has fallen by -$109.80 million (-16.79%). ITCI annual working capital is now -16.87% below its all-time high of $654.72 million, reached on December 31, 2022.ITCI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Working Capital
$1.11 B
+$3.14 M+0.28%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly working capital is $1.11 billion, with the most recent change of +$3.14 million (+0.28%) on September 30, 2024. Over the past year, it has increased by +$506.29 million (+84.47%). ITCI quarterly working capital is now at all-time high.ITCI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.9% | +84.5% |
| 3 y3 years | -16.8% | +84.5% |
| 5 y5 years | +70.5% | +84.5% |
ITCI Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | +31.5% | at high | +167.1% |
| 5 y | 5-year | -16.9% | +180.4% | at high | +469.6% |
| alltime | all time | -16.9% | >+9999.0% | at high | >+9999.0% |
Intra-Cellular Therapies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.11 B(+0.3%) |
| June 2024 | - | $1.10 B(+98.4%) |
| Mar 2024 | - | $555.73 M(+2.1%) |
| Dec 2023 | $544.25 M(-16.9%) | $544.25 M(-9.2%) |
| Sept 2023 | - | $599.33 M(-1.1%) |
| June 2023 | - | $605.99 M(-3.3%) |
| Mar 2023 | - | $626.51 M(-4.3%) |
| Dec 2022 | $654.72 M(+58.2%) | $654.72 M(-4.0%) |
| Sept 2022 | - | $682.35 M(-5.0%) |
| June 2022 | - | $718.57 M(-9.0%) |
| Mar 2022 | - | $789.27 M(+90.7%) |
| Dec 2021 | $413.92 M(-36.7%) | $413.92 M(-14.4%) |
| Sept 2021 | - | $483.35 M(-12.3%) |
| June 2021 | - | $550.88 M(-9.6%) |
| Mar 2021 | - | $609.40 M(-6.8%) |
| Dec 2020 | $654.05 M(+237.0%) | $654.05 M(-7.5%) |
| Sept 2020 | - | $706.84 M(+86.8%) |
| June 2020 | - | $378.33 M(-12.0%) |
| Mar 2020 | - | $429.90 M(+121.5%) |
| Dec 2019 | $194.10 M(-39.2%) | $194.10 M(-14.1%) |
| Sept 2019 | - | $226.08 M(-11.6%) |
| June 2019 | - | $255.82 M(-11.1%) |
| Mar 2019 | - | $287.63 M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $319.14 M(-29.9%) | $319.14 M(-9.9%) |
| Sept 2018 | - | $354.12 M(-9.4%) |
| June 2018 | - | $390.73 M(-7.7%) |
| Mar 2018 | - | $423.50 M(-6.9%) |
| Dec 2017 | $455.01 M(+20.5%) | $455.01 M(+41.5%) |
| Sept 2017 | - | $321.56 M(-5.9%) |
| June 2017 | - | $341.87 M(-3.8%) |
| Mar 2017 | - | $355.29 M(-5.9%) |
| Dec 2016 | $377.67 M(-20.8%) | $377.67 M(-5.8%) |
| Sept 2016 | - | $401.13 M(-6.2%) |
| June 2016 | - | $427.43 M(-5.8%) |
| Mar 2016 | - | $453.91 M(-4.8%) |
| Dec 2015 | $476.99 M(+296.1%) | $476.99 M(-5.0%) |
| Sept 2015 | - | $501.88 M(+146.9%) |
| June 2015 | - | $203.29 M(-8.4%) |
| Mar 2015 | - | $221.90 M(+84.3%) |
| Dec 2014 | $120.43 M(+283.3%) | $120.43 M(-10.1%) |
| Sept 2014 | - | $133.90 M(-3.3%) |
| June 2014 | - | $138.47 M(-2.8%) |
| Mar 2014 | - | $142.46 M(+353.5%) |
| Dec 2013 | $31.42 M(<-9900.0%) | $31.42 M(-20.2%) |
| Sept 2013 | - | $39.35 M(<-9900.0%) |
| June 2013 | - | -$33.00 K |
| Mar 2013 | -$22.10 K | - |
FAQ
- What is Intra-Cellular Therapies annual working capital?
- What is the all time high annual working capital for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual working capital year-on-year change?
- What is Intra-Cellular Therapies quarterly working capital?
- What is the all time high quarterly working capital for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly working capital year-on-year change?
What is Intra-Cellular Therapies annual working capital?
The current annual working capital of ITCI is $544.25 M
What is the all time high annual working capital for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual working capital is $654.72 M
What is Intra-Cellular Therapies annual working capital year-on-year change?
Over the past year, ITCI annual working capital has changed by -$110.47 M (-16.87%)
What is Intra-Cellular Therapies quarterly working capital?
The current quarterly working capital of ITCI is $1.11 B
What is the all time high quarterly working capital for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly working capital is $1.11 B
What is Intra-Cellular Therapies quarterly working capital year-on-year change?
Over the past year, ITCI quarterly working capital has changed by +$506.29 M (+84.47%)